ALINITY I PIVKA-II.
Mexico·Clase I·III. DIAGNOSTIC AGENTS·ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.·Registered December 13, 2019EL ENSAYO ALINITY I PIVKA-II (PROTEÍNA INDUCIDA POR LA AUSENCIA DE VITAMINA K O ANTAGONISTA-II) ES UN INMUNOANÁLISIS QUIMIOLUMINISCENTE DE MICROPARTÍCULAS (CMIA) PARA LA DETERMINACIÓN CUANTITATIVA DE PIVKA-II EN SUERO O PLASMA HUMANOS EN EL ANALIZADOR ALI
THE ALINITY I PIVKA-II ASSAY (VITAMIN K-INDUCED PROTEIN OR ANTAGONIST-II) IS A MICROPARTICLE CHEMILUMINESCENT IMMUNOASSAY (CMIA) FOR THE QUANTITATIVE DETERMINATION OF PIVKA-II IN HUMAN SERUM OR PLASMA ON THE ALI ANALYZER
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓN DE PIVKA-II.
- Trade Name (English)
- TEST FOR THE DETERMINATION OF PIVKA-II.
- Analysis ID
- 2286R2019 SSA
- Registration Date
- December 13, 2019
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ALINITY I PIVKA-II. (ALINITY I PIVKA-II.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2286R2019 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on December 13, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.